NATIONAL BUREAU OF ECONOMIC RESEARCH
NATIONAL BUREAU OF ECONOMIC RESEARCH
loading...

Therapeutic Translation of Genomic Science: Opportunities and limitations of GWAS

Manuel I. Hermosilla, Jorge A. Lemus

NBER Working Paper No. 23989
Issued in November 2017, Revised in March 2018
NBER Program(s):Health Care, Productivity, Innovation, and Entrepreneurship

Many scientists predicted a swift revolution in human therapeutics after the completion of the Human Genome Project (“HGP”). This revolution, however, has been slow to materialize in spite of the scientific advances. We investigate the role of biological complexity in slowing down this revolution. Our test relies on a disease-specific measure of biological complexity, constructed by drawing on insights from Network Medicine (Barabási et al., 2011). According to our measure, more complex diseases are associated with a larger number of genetic mutations—higher centrality in the Human Disease Network (Goh et al., 2007). With this measure in hand, we estimate the rate of translation of new science into early-stage drug innovation by focusing on a leading type of genetic epidemiological knowledge (Genome-Wide Association Studies), and employing standard methods for the measurement of R&D productivity. For less complex diseases, we find a strong and positive association between cumulative knowledge and the amount of innovation. This association weakens as complexity increases, becoming statistically insignificant at the extreme. Our results suggest that biological complexity is, in part, responsible for the slower-than-expected unfolding of the therapeutical revolution set in motion by the HGP.

You may purchase this paper on-line in .pdf format from SSRN.com ($5) for electronic delivery.

Access to NBER Papers

You are eligible for a free download if you are a subscriber, a corporate associate of the NBER, a journalist, an employee of the U.S. federal government with a ".GOV" domain name, or a resident of nearly any developing country or transition economy.

If you usually get free papers at work/university but do not at home, you can either connect to your work VPN or proxy (if any) or elect to have a link to the paper emailed to your work email address below. The email address must be connected to a subscribing college, university, or other subscribing institution. Gmail and other free email addresses will not have access.

E-mail:

The NBER Bulletin on Aging and Health provides summaries of publications like this.  You can sign up to receive the NBER Bulletin on Aging and Health by email.

Machine-readable bibliographic record - MARC, RIS, BibTeX

Document Object Identifier (DOI): 10.3386/w23989

Forthcoming: Therapeutic Translation of Genomic Science: Opportunities and Limitations of GWAS, Manuel Hermosilla, Jorge Lemus. in Economic Dimensions of Personalized and Precision Medicine, Berndt, Goldman, and Rowe. 2018

Users who downloaded this paper also downloaded* these:
McGeary, Dave, Lipton, and Roeper w23995 Impact of Comprehensive Smoking Bans on the Health of Infants and Children
Barjamovic, Chaney, Coşar, and Hortaçsu w23992 Trade, Merchants, and the Lost Cities of the Bronze Age
Gallego, Malamud, and Pop-Eleches w23982 Parental Monitoring and Children's Internet Use: The Role of Information, Control, and Cues
Galasso and Schankerman w20269 Patents and Cumulative Innovation: Causal Evidence from the Courts
Carpenter and Stehr w15658 Intended and Unintended Effects of Youth Bicycle Helmet Laws
 
Publications
Activities
Meetings
NBER Videos
Themes
Data
People
About

National Bureau of Economic Research, 1050 Massachusetts Ave., Cambridge, MA 02138; 617-868-3900; email: info@nber.org

Contact Us